Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
marketwatch.com
science
2022-06-01 21:18:00

Shares of Regeneron Pharmaceuticals Inc. REGN, -0.88% slipped 0.88% to $658.92 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX, -0.75% falling 0.75% to 4,101.23 and Dow Jones Industrial Average DJIA, -0.54% falling 0.54% to 32,813.23. This was the stock's second consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $88.50 short of its 52-week high ($747.42), which the company achieved on April 8th. Despite its losses, the stock outperformed some of its competitors Wednesday, as Johnson & Johnson JNJ, -1.
